Long non-coding RNA BC002811 Promotes Gastric Cancer Metastasis by Regulating SOX2 Binding to the PTEN Promoter

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Long non-coding RNAs (lncRNAs) play a role in gastric cancer (GC) pathogenesis.
• The specific mechanisms of lncRNA involvement in GC progression are not fully understood.

Purpose of the Study:

• To identify and characterize the role of lncRNA BC002811 in gastric cancer development and progression.
• To elucidate the molecular mechanisms underlying BC002811's function in GC.

Main Methods:

• Quantitative real-time PCR (qRT-PCR) to assess BC002811 expression in GC tissues and cell lines.
• In vitro assays (proliferation, migration, invasion, apoptosis) and in vivo tumor xenograft models to evaluate BC002811's functional impact.
• Western blotting and luciferase reporter assays to investigate the regulatory pathways involving BC002811, PTEN, and SOX2.

Main Results:

• BC002811 was significantly upregulated in GC tissues and cell lines, correlating with reduced patient survival.
• Overexpression of BC002811 promoted GC cell proliferation, migration, invasion, inhibited apoptosis, and accelerated tumor growth and metastasis in vivo.
• BC002811 upregulated MMP2 and MMP9 expression and promoted metastasis by downregulating PTEN, potentially by acting as a molecular decoy for SOX2 and inhibiting PTEN transcription.

Conclusions:

• lncRNA BC002811 is a critical oncogenic regulator in gastric cancer progression and metastasis.
• BC002811's mechanism involves modulating PTEN expression via interaction with SOX2.
• BC002811 represents a potential therapeutic target for inhibiting GC metastasis.